Skip to main content

Peer Review reports

From: Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features

Original Submission
20 Nov 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
26 Mar 2015 Editorially accepted
14 Apr 2015 Article published 10.1186/s12885-015-1274-1

You can find further information about peer review here.

Back to article page